No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

California Scientific Instrument Manufacturer Applied Extracts Begins Development of Novel Sterilization Technology with Potential COVID-19 Coronavirus Applications

Editor: What To Know

  • ” The company's technology does not rely on gamma radiation, or high heat, and could be applied to the sterilization of medical devices, garments, gloves, and masks used by first responders and medical professionals responding to the coronavirus emergency.
  • The company's technology could be particularly important in the event that disposable protective garments have to be re-used due to the shortages that may currently exist in the United States.
  • D, who received his doctorate in Mechanical Engineering from the Massachusetts Institute of Technology and was formerly a Division President at Bruker BioSpin, a global scientific equipment manufacturer.

Applied Extracts is developing a novel environmentally friendly sterilization technology with broad potential applications including mitigating the spread of the Coronavirus and other pathogens.

The company’s founder and chief engineer Dr. James White, Ph.D., stated, “Environmentally friendly sterilization technologies have the potential to improve the way medical services are delivered. We foresee broad potential applications for this technology.” The company’s technology does not rely on gamma radiation, or high heat, and could be applied to the sterilization of medical devices, garments, gloves, and masks used by first responders and medical professionals responding to the coronavirus emergency. The company’s technology could be particularly important in the event that disposable protective garments have to be re-used due to the shortages that may currently exist in the United States.

Applied Extracts was founded in 2017 by Dr. James White, Ph.D, who received his doctorate in Mechanical Engineering from the Massachusetts Institute of Technology and was formerly a Division President at Bruker BioSpin, a global scientific equipment manufacturer. Colleen Labadie White, former Associate Director of Regulatory Project Management at Beigene, Inc., is leading the company’s regulatory compliance initiative.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy